NCT07405190
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07405190
Title Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Massachusetts General Hospital
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA